Success Stories: An Indian Graduate Assistant in Pharmaceutical Science with 39 Peer Reviews Obtains NIW Approval with Our Diligent Help

Client’s Testimonial:

“Thanks to you for helping me with filling out the EB2 application. You have been great throughout the process.”

On May 16^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Assistant in the Field of Pharmaceutical Science (Approval Notice).

General Field: Pharmaceutical Science

Position at the Time of Case Filing: Graduate Assistant

Country of Origin: India

State of Residence at the Time of Filing: Iowa

Approval Notice Date: May 16^th, 2022

Processing Time: 5 months, 4 days

Case Summary:

“[Client’s] development of novel approaches to characterize and improve the physical properties of solid drug formulations, such as solubility, is integral to the effort to increase the effectiveness of pharmaceutical agents and in turn decrease associated manufacturing costs. By developing widely applicable means to increase the solubility of solid drug formulations, [the client] is directly improving and innovating the field of pharmaceutical science and ensuring that safer and more effective medications are made available to patients within the United States, without the barrier of higher cost.”

The above statement is part of a longer testimonial of support issued in favor of one of our clients from India. She was a graduate assistant in pharmaceutical science and as an expert in the field her proposed endeavors to analyze and characterize cocrystals and amorphous solids in order to enhance aqueous solubility, improve physical drug characteristics, and support pharmaceutical product development. Among other applications, her work was relevant to the improvement of drug properties for cancer, Raynaud’s phenomenon, and other diseases.

Importantly, her work was of great importance because it improved critical properties of pharmaceutical products, supporting public health and the success of the pharmaceutical industry. Her research has contributed innovative strategies for improving solubility and other drug properties, offering improved treatment methods for a variety of diseases. The broad applicability of these advancements and the significance of the global pharmaceutical market is thus strong evidence of the importance of her research.

At the same time she has completed at least 39 reviews to date and her work has been published in 13 peer-reviewed journal articles (4 of them first-authored) and 1 first-authored book chapter.

These publications have also been cited a total of 140 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of pharmaceutical science.

Thus, her 8 years of work in the field was indeed helpful in giving her an upper hand in the field. Her expertise is much valued and her work is of great interest to the United States of America. We are glad to have worked with her on the case and help her get the approval without an RFE in just 6 months.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.